Speaker illustration

Mr Md Elias Al-Mamun

Tohoku University Graduate School of Medicine, Sendai (Japan)

Rivaroxaban prevents the development of chronic thromboembolic pulmonary hypertension in mice- Novel beneficial effects of the FXa inhibitor-

Event: ESC CONGRESS 2017

Topic: Treatment of hypertension

Session: What is new in venous thromboembolism?


This platform is supported by

logo Novo Nordisk